2025 annual financial data
Zevra Therapeutics 2025 Operating margin
Direct answer
Operating margin was -3.98%.
Operating income was -4,233,000 USD and net income was 83,229,000 USD.
Operating cash flow was -1,598,000 USD.
Get free Zevra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 106,470,000 USD
- Operating income
- -4,233,000 USD
- Net income
- 83,229,000 USD
- Operating cash flow
- -1,598,000 USD